Get informed when a big investor buys or sells
+ FollowOvervalued by 124.1% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $77.31 Million |
|---|---|
| Enterprise Value | $179.10 Million |
| Earnings per Share | $-0.43 |
| Beta | -0.57 |
| Outstanding Shares | 493,379,000 |
| P/E Ratio | -2.88 |
|---|---|
| PEG | -0.52 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.21 |
| Enterprise Value to EBIT | -0.63 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.75 |
| Debt to Equity | 1.22 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Kintor Pharmaceutical Limited, a biotechnology firm in its clinical development phase, is dedicated to the discovery, advancement, and marketing of a diverse array of small molecule and biological therapies. The company primarily concent...